• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对心血管外科病房患者流行性非甲非乙型肝炎的抗原/抗体系统。

An antigen/antibody system specific for an epidemic non-A, non-B hepatitis in patients of a cardiovascular surgical unit.

作者信息

Ohori H, Kanno A, Nagatsuka Y, Yamada E, Onodera S, Tateda A, Abe Y, Togoh T, Ishida N

出版信息

J Med Virol. 1983;12(3):161-78. doi: 10.1002/jmv.1890120302.

DOI:10.1002/jmv.1890120302
PMID:6415237
Abstract

The antigen/antibody systems specific for non-A, non-B hepatitis (NANB) were studied using urine samples as the antigen source and sera for the antibody source. Two immunologically distinct systems, SO-antigen/anti-SO and MI-antigen/anti-MI were discovered. This paper deals chiefly with the characterization of the SO-antigen, which was associated with an epidemic-type non-A, non-B hepatitis found during September 1979 to February 1980 (first outbreak) and October 1980 to January 1981 (second outbreak) in the Cardiovascular Surgical Unit of Tohoku University Hospital. All patients who developed non-A, non-B hepatitis during the first and second epidemic periods had SO-antigen in their urine (24 out of 24). After the epidemic, however, the detection rate of SO-antigen gradually decreased among patients in the same unit, although posttransfusion non-A, non-B hepatitis continued to be found. The final detection of SO-antigen occurred at or just after the elevation of alanine aminotransferase (ALT) levels during the episode of hepatitis and persisted in most cases throughout the elevated period. Anti-SO antibody was detected relatively late (eight months after blood transfusion, in most cases) and apparently persisted longer than five years. The immunological and physicochemical properties of SO-antigen were also studied. It appeared to be neither a plasma protein nor a liver tissue component when the cross-reactivity of SO-antigen was examined by the immunodiffusion method. Absorption with insolubilized human serum and liver tissues failed to affect the anti-SO antibody activity. The molecular weight of SO-antigen was estimated to be 250,000, the sedimentation coefficient to be 11.0 S, and the buoyant density in CsCl to be 1.215 g/cm3. Electron microscopy showed that the SO-antigen corresponded with uniform particles with a mean diameter of 11 nm. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of SO-antigen revealed only a single protein band corresponding to molecular weight 38,000.

摘要

以尿液样本作为抗原来源、血清作为抗体来源,对非甲非乙型肝炎(NANB)特异性的抗原/抗体系统进行了研究。发现了两个免疫上不同的系统,即SO抗原/抗SO和MI抗原/抗MI。本文主要论述SO抗原的特性,该抗原与1979年9月至1980年2月(首次暴发)以及1980年10月至1981年1月(第二次暴发)在东北大学医院心血管外科病房发现的流行性非甲非乙型肝炎有关。在第一次和第二次流行期间发生非甲非乙型肝炎的所有患者尿液中均有SO抗原(24例患者全部如此)。然而,流行过后,同一病房患者中SO抗原的检出率逐渐下降,尽管仍不断发现输血后非甲非乙型肝炎病例。SO抗原的最后检出发生在肝炎发作期间丙氨酸转氨酶(ALT)水平升高之时或之后不久,并且在大多数情况下在升高期一直存在。抗SO抗体相对较晚才被检测到(大多数情况下在输血后8个月),而且显然持续存在超过5年。还研究了SO抗原的免疫学和物理化学特性。当通过免疫扩散法检测SO抗原的交叉反应性时,它似乎既不是血浆蛋白也不是肝组织成分。用人血清和肝组织的不溶性制剂进行吸收,并不影响抗SO抗体活性。估计SO抗原的分子量为250,000,沉降系数为11.0 S,在氯化铯中的浮力密度为1.215 g/cm3。电子显微镜检查显示,SO抗原与平均直径为11 nm的均匀颗粒相对应。对SO抗原进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)分析,仅显示出一条对应于分子量38,000的单一蛋白带。

相似文献

1
An antigen/antibody system specific for an epidemic non-A, non-B hepatitis in patients of a cardiovascular surgical unit.一种针对心血管外科病房患者流行性非甲非乙型肝炎的抗原/抗体系统。
J Med Virol. 1983;12(3):161-78. doi: 10.1002/jmv.1890120302.
2
AN6520 Ag: an antigen purified from liver with non-A, non-B hepatitis.AN6520抗原:一种从非甲非乙型肝炎患者肝脏中纯化得到的抗原。
J Med Virol. 1985 Apr;15(4):357-71. doi: 10.1002/jmv.1890150406.
3
Non-A, Non-B hepatitis virus: identification of a core antigen-antibody system that cross reacts with hepatitis B core antigen and antibody.非甲非乙型肝炎病毒:一种与乙型肝炎核心抗原和抗体发生交叉反应的核心抗原-抗体系统的鉴定。
J Med Virol. 1981;8(1):31-47. doi: 10.1002/jmv.1890080103.
4
Biophysical properties and morphology of purified antigen associated with non-A, non-B hepatitis.与非甲非乙型肝炎相关的纯化抗原的生物物理特性及形态学
Med Microbiol Immunol. 1986;175(4):229-39. doi: 10.1007/BF02123731.
5
Detection of virus-associated antigen in serum and liver of patients with non-A non-B hepatitis.非甲非乙型肝炎患者血清及肝脏中病毒相关抗原的检测
Lancet. 1979 Dec 15;2(8155):1263-7. doi: 10.1016/s0140-6736(79)92280-3.
6
Demonstration of a single antigen-antibody system in 26 patients with non-A, non-B viral hepatitis.26例非甲非乙型病毒性肝炎患者单一抗原抗体系统的验证
Lancet. 1982 Oct 23;2(8304):899-90. doi: 10.1016/s0140-6736(82)90867-4.
7
Post-transfusion hepatitis: antigen/antibody systems correlated with non-A, non-B hepatitis.输血后肝炎:与非甲非乙型肝炎相关的抗原/抗体系统
J Med Virol. 1980;6(2):147-51. doi: 10.1002/jmv.1890060207.
8
Detection by immunofluorescence of a new "core-like" Ag/Ab system in liver and serum of patients with NANB hepatitis.用免疫荧光法检测非甲非乙型肝炎患者肝脏和血清中一种新的“核心样”抗原/抗体系统。
Liver. 1981 Sep;1(3):191-200. doi: 10.1111/j.1600-0676.1981.tb00033.x.
9
An enzyme-linked immunosorbent assay for an antigen related to non-A, non-B hepatitis and its antibody: partial characterization of the antigen and chimpanzee transmission.一种针对与非甲非乙型肝炎相关抗原及其抗体的酶联免疫吸附测定:抗原的部分特性及在黑猩猩中的传播
J Med Virol. 1983;11(1):11-21. doi: 10.1002/jmv.1890110103.
10
Seroepidemiological studies on a non-A, non-B hepatitis specific antigen/antibody system (SO-antigen/anti-SO).关于一种非甲非乙型肝炎特异性抗原/抗体系统(SO抗原/抗SO)的血清流行病学研究。
J Med Virol. 1986 Jan;18(1):1-10. doi: 10.1002/jmv.1890180102.